Expanding Access to MAT for People with Opioid Use Disorders

October 13th, 2016

The Substance Abuse and Mental Health Services Administration (SAMHSA), as part of the US Department of Health and Human Services (HHS), has issued new reporting requirements for physicians who will be authorized to prescribe the opioid use disorder treatment medication buprenorphine at the new limit of 275 patients. The requirements, published on September 27, 2016 in the Federal Register, are a key step in increasing access to medication-assisted treatment for opioid-related disorders.

See Bulletin

Read Requirements

Posted in Content


A Project of the Governor's Institute on Alcohol & Substance Abuse and the North Carolina Society of Addiction Medicine.
Funded wholly or in part by the federal Substance Abuse Prevention and Treatment Block Grant Fund (CFDA #93.959) as a project of the NC Division of Mental Health, Developmental Disabilities & Substance Abuse Services.